Infusion Reactions After Receiving the Broadly Neutralizing Antibody VRC01 or Placebo to Reduce HIV-1 Acquisition: Results From the Phase 2b Antibody-Mediated Prevention Randomized TrialsP. Andrew, John Hural, Larissa M. Villela et al.|UNC Libraries|2023Cited by 0
Feasibility and Successful Enrollment in a Proof-of-Concept HIV Prevention Trial of VRC01, a Broadly Neutralizing HIV-1 Monoclonal AntibodyDavid Burns, Gail Broder, John Hural et al.|UNC Libraries|2023Cited by 0
A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline FindingsMark Anderson, Michal Juraska, India Tindale et al.|UNC Libraries|2023Cited by 0